BackgroundMetabolic syndrome (MetSyn) is an epidemic in the United States and is associated with early onset of atherosclerosis, increased thrombotic events, and increased complications after cardiovascular intervention. MetSyn is found in ∼50% of patients with peripheral vascular disease. However, its impact on peripheral interventions is unknown. The aim of this study is to determine the outcomes of superficial femoral artery (SFA) interventions in patients with and without MetSyn.MethodsA database of patients undergoing endovascular treatment of SFA disease between 1999 and 2009 was retrospectively queried. MetSyn was defined as the presence of ≥3 of the following criteria: blood pressure ≥130 mm Hg/≥85 mm Hg; triglycerides ≥150 mg/dL; h...
Little is known about the prognostic significance of specific characteristics of magnetic resonance ...
BackgroundAlthough aggressive endoluminal therapy for superficial femoral artery (SFA) occlusive dis...
Aims: The aim of this study is to evaluate the impact of metabolic syndrome (MetS) on clinical sever...
BackgroundMetabolic syndrome (MetSyn) is an epidemic in the United States and is associated with ear...
Objective: Metabolic syndrome (MetSyn) is a well-known risk factor for cardiovascular (CV) disease i...
BACKGROUND AND AIMS: Metabolic syndrome (MetS) was reported to be associated with increased cardiova...
Prior studies evaluating metabolic syndrome (MetS) and incident peripheral artery disease (PAD) have...
BackgroundEndovascular therapy for symptomatic atherosclerotic renal artery stenosis (ARAS) is commo...
ObjectivesPeripheral arterial occlusive disease (PAOD) is associated with a high risk of cardiovascu...
PurposeThe metabolic syndrome, a cluster of cardiovascular risk factors associated with insulin resi...
Context. Metabolic syndrome (MetS) refers to the combination of abdominal obesity, hyperglycemia or ...
ObjectivesThe aim of this study was to describe associations of the presence of lipid-rich necrotic ...
BACKGROUND:Statins are guidelines recommended in patients with peripheral artery disease (PAD) for t...
ObjectiveThe natural history of patients with metabolic syndrome (MetS) undergoing hemodialysis acce...
SummaryBackgroundMetabolic syndrome (MS) associated with systemic inflammation identifies high-risk ...
Little is known about the prognostic significance of specific characteristics of magnetic resonance ...
BackgroundAlthough aggressive endoluminal therapy for superficial femoral artery (SFA) occlusive dis...
Aims: The aim of this study is to evaluate the impact of metabolic syndrome (MetS) on clinical sever...
BackgroundMetabolic syndrome (MetSyn) is an epidemic in the United States and is associated with ear...
Objective: Metabolic syndrome (MetSyn) is a well-known risk factor for cardiovascular (CV) disease i...
BACKGROUND AND AIMS: Metabolic syndrome (MetS) was reported to be associated with increased cardiova...
Prior studies evaluating metabolic syndrome (MetS) and incident peripheral artery disease (PAD) have...
BackgroundEndovascular therapy for symptomatic atherosclerotic renal artery stenosis (ARAS) is commo...
ObjectivesPeripheral arterial occlusive disease (PAOD) is associated with a high risk of cardiovascu...
PurposeThe metabolic syndrome, a cluster of cardiovascular risk factors associated with insulin resi...
Context. Metabolic syndrome (MetS) refers to the combination of abdominal obesity, hyperglycemia or ...
ObjectivesThe aim of this study was to describe associations of the presence of lipid-rich necrotic ...
BACKGROUND:Statins are guidelines recommended in patients with peripheral artery disease (PAD) for t...
ObjectiveThe natural history of patients with metabolic syndrome (MetS) undergoing hemodialysis acce...
SummaryBackgroundMetabolic syndrome (MS) associated with systemic inflammation identifies high-risk ...
Little is known about the prognostic significance of specific characteristics of magnetic resonance ...
BackgroundAlthough aggressive endoluminal therapy for superficial femoral artery (SFA) occlusive dis...
Aims: The aim of this study is to evaluate the impact of metabolic syndrome (MetS) on clinical sever...